BioRestorative Therapies Inc (BRTX)-医療機器分野:企業M&A・提携分析

◆英語タイトル:BioRestorative Therapies Inc (BRTX) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8012901
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月27日
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
BioRestorative Therapies Inc (BRT), formerly Stem Cell Assurance Inc is a developer of therapeutic products and medical therapies. The company performs stem cell programs which include brtxDISC and ThermoStem. brtxDISC,a lead therapeutic product, is designed to offer a non-surgical treatment for chronic lumbar disc diseases such as bulging and herniated discs. The company’s ThermoStem program develops brown fat stem cell-based therapy which is used for the treatment of type 2 diabetes, obesity, and other metabolic disorders. It offers identification and treatment of first stem cell population isolated from a particular brown fat depot in humans. BRT is headquartered in Melville, New York, the US.

BioRestorative Therapies Inc (BRTX) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
BioRestorative Therapies Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
BioRestorative Therapies Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
BioRestorative Therapies Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
BioRestorative Therapies Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
BioRestorative Therapies Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
BioRestorative Therapies Inc, Medical Equipment, Deal Details 10
BioRestorative Therapies Enters Into Licensing Agreement With Regenerative Sciences For Stem Cell Disc And Spine Procedure 10
Equity Offering 11
BioRestorative Therapies Files Registration Statement for Public Offering of Shares and Warrants for up to USD15 Million 11
Debt Offering 12
BioRestorative Therapies Raises USD0.2 Million in Private Placement of 8% Note Due 2017 12
BioRestorative Therapies Raises USD0.24 Million in Private Placement of 8% Note Due 2017 13
BioRestorative Therapies Raises USD0.21 Million in Private Placement of 8% Note Due 2017 14
BioRestorative Therapies Inc – Key Competitors 15
BioRestorative Therapies Inc – Key Employees 16
BioRestorative Therapies Inc – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Corporate Communications 18
Feb 23, 2016: BioRestorative Therapies Deepens Board of Directors With Addition of Robert B. Catell, Former Chairman and CEO of KeySpan Corporation and Chairman of National Grid, US 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
BioRestorative Therapies Inc, Medical Equipment, Key Facts, 2016 2
BioRestorative Therapies Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
BioRestorative Therapies Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
BioRestorative Therapies Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
BioRestorative Therapies Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
BioRestorative Therapies Inc, Deals By Market, 2011 to YTD 2017 8
BioRestorative Therapies Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
BioRestorative Therapies Enters Into Licensing Agreement With Regenerative Sciences For Stem Cell Disc And Spine Procedure 10
BioRestorative Therapies Files Registration Statement for Public Offering of Shares and Warrants for up to USD15 Million 11
BioRestorative Therapies Raises USD0.2 Million in Private Placement of 8% Note Due 2017 12
BioRestorative Therapies Raises USD0.24 Million in Private Placement of 8% Note Due 2017 13
BioRestorative Therapies Raises USD0.21 Million in Private Placement of 8% Note Due 2017 14
BioRestorative Therapies Inc, Key Competitors 15
BioRestorative Therapies Inc, Key Employees 16
BioRestorative Therapies Inc, Subsidiaries 17

★海外企業調査レポート[BioRestorative Therapies Inc (BRTX)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Seafarms Group Ltd (SFG):企業の財務・戦略的SWOT分析
    Seafarms Group Ltd (SFG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • United Biscuits (UK) Limited:企業の戦略・SWOT・財務情報
    United Biscuits (UK) Limited - Strategy, SWOT and Corporate Finance Report Summary United Biscuits (UK) Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Huron Consulting Group Inc
    Huron Consulting Group Inc - Strategy, SWOT and Corporate Finance Report Summary Huron Consulting Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • AnaMar AB:医療機器:M&Aディール及び事業提携情報
    Summary AnaMar AB (AnaMar), a subsidiary of Koncentra Holding AB, is a drug discovery company that discovers, develops and commercializes therapeutic strategies to treat debilitating inflammation, fibrosis and pain. The company develops drug candidates from several chemical classes on the receptors …
  • HD Biosciences (China) Co Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary HD Biosciences (China) Co Ltd (HDB), a subsidiary of WuXi AppTec (Shanghai) Co Ltd, is a contract research organization that offers drug discovery research services. The organization develops and provides products such as mycoplasma detection kit and wash free calcium assay kit, among others …
  • Adris grupa d.d.:企業の戦略・SWOT・財務情報
    Adris grupa d.d. - Strategy, SWOT and Corporate Finance Report Summary Adris grupa d.d. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • TransAlta Corp:企業の発電所・SWOT分析2018
    TransAlta Corp - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (exe …
  • Mizuho Bank Ltd:企業のM&A・事業提携・投資動向
    Mizuho Bank Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Mizuho Bank Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Ossur hf (OSSR):企業の財務・戦略的SWOT分析
    Ossur hf (OSSR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Relentless Resources Ltd (RRL):石油・ガス:M&Aディール及び事業提携情報
    Summary Relentless Resources Ltd (Relentless Resources), formerly New Range Resources Ltd is an oil and gas company that offers oil and gas exploration and development services. The company acquires, explores, operates, manages, produces, and develops crude oil and natural gas in Alberta and Saskatc …
  • Ranhill Holdings Berhad (RANHILL):企業の財務・戦略的SWOT分析
    Ranhill Holdings Berhad (RANHILL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Accelerate Diagnostics Inc (AXDX):企業の財務・戦略的SWOT分析
    Accelerate Diagnostics Inc (AXDX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • China International Water & Electric Corp:企業の戦略的SWOT分析
    China International Water & Electric Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • Targa Resources Corp.:企業の戦略・SWOT・財務情報
    Targa Resources Corp. - Strategy, SWOT and Corporate Finance Report Summary Targa Resources Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Sensient Technologies Corp (SXT):企業の財務・戦略的SWOT分析
    Sensient Technologies Corp (SXT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Compugen Ltd (CGEN)-製薬・医療分野:企業M&A・提携分析
    Summary Compugen Ltd (Compugen) is a drug discovery company that develops medicines for immuno-oncology and autoimmune diseases. The company’s immuno-oncology pipeline comprises CGEN-15001T, CGEN-15022, CGEN-15022, CGEN-15029, target candidates, immuno-modulatory target candidates and ADC target can …
  • Glow Energy Public Co Ltd (GLOW)-エネルギー分野:企業M&A・提携分析
    Summary Glow Energy Public Company Limited (Glow Energy), a subsidiary of Engie S.A., is an energy utility company. It generates and supplies electricity to Electricity Generating Authority of Thailand (EGAT). The company also generates and supplies electricity, steam, processed water and chilled wa …
  • Riemser Pharma GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary Riemser Pharma GmbH (Riemser), formerly Riemser Arzneimittel AG is a distributor of lifecycle management products. The company offers analgesics products, cardiovascular products, over-the-counter medicines, prescription drugs and dental products. It provides medical products for the treatme …
  • Reliance Industries Limited:企業の戦略・SWOT・財務情報
    Reliance Industries Limited - Strategy, SWOT and Corporate Finance Report Summary Reliance Industries Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • TELUS Corporation:企業の戦略・SWOT・財務情報
    TELUS Corporation - Strategy, SWOT and Corporate Finance Report Summary TELUS Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆